BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19399963)

  • 1. Current world literature. Trauma and transfusion.
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):321-5. PubMed ID: 19399963
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of trauma-induced coagulopathy: trends and practices.
    D'Angelo MR; Dutton RP
    AANA J; 2010 Feb; 78(1):35-40. PubMed ID: 20977127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive transfusion and nonsurgical hemostatic agents.
    Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
    Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion in trauma: why and how should we change our current practice?
    Theusinger OM; Spahn DR; Ganter MT
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):305-12. PubMed ID: 19390257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trauma and transfusion.
    Zacharowski K
    Curr Opin Anaesthesiol; 2017 Apr; 30(2):242. PubMed ID: 28092271
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury.
    Christians K; Brasel K; Garlitz J; Abu-Hajir M; Gottschall J
    J Trauma; 2005 Sep; 59(3):742-6. PubMed ID: 16361923
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedure for critical nonsurgical bleeding].
    Grottke O; Rossaint R
    Chirurg; 2007 Feb; 78(2):101-2, 104-9. PubMed ID: 17265055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
    Bauzá G; Hirsch E; Burke P; Quillen K
    Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trauma-induced coagulopathy.
    Godier A; Susen S
    Ann Fr Anesth Reanim; 2013; 32(7-8):527-30. PubMed ID: 23916515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acquired bleeding problems in cancer patients.
    DeLoughery TG
    Emerg Med Clin North Am; 2009 Aug; 27(3):423-44. PubMed ID: 19646646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
    Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
    Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant factor VIIa in trauma patients.
    Talbot M; Tien HC
    J Am Acad Orthop Surg; 2009 Aug; 17(8):477-81. PubMed ID: 19652029
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma.
    Holcomb JB
    J Trauma; 2005 Jun; 58(6):1298-303. PubMed ID: 15995488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute traumatic haemorrhagic shock and transfusion: what's new in 2009?].
    Morel N; Morel O; Chimot L; Lortet V; Julliac B; Lelias A; Merson L; Dabadie P
    Ann Fr Anesth Reanim; 2009 Mar; 28(3):222-30. PubMed ID: 19278810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy in trauma patients: what are the main influence factors?
    Maani CV; DeSocio PA; Holcomb JB
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):255-60. PubMed ID: 19300245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.
    Barcelona SL; Thompson AA; Coté CJ
    Paediatr Anaesth; 2005 Oct; 15(10):814-30. PubMed ID: 16176309
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
    Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
    J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.